Astrazeneca Plc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC AZN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

194,865

Value ($000)

17,914

Weight

0.0%

2014 Q1 - 2025 Q4 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	17,914	0.0%	194,865	12/31/2025
2025 Q1	5/19/2025	676	0.0%	9,200	3/31/2025
2024 Q4	2/14/2025	12,026	0.0%	183,548	12/31/2024
2023 Q2	8/11/2023	13,479	0.0%	194,200	6/30/2023
2023 Q1	5/15/2023	13,479	0.0%	194,200	3/31/2023
2022 Q3	11/14/2022	12,312	0.0%	224,500	9/30/2022
2022 Q2	8/12/2022	18,321	0.0%	277,300	6/30/2022
2022 Q1	5/16/2022	1,600	0.0%	24,115	3/31/2022
2021 Q4	2/14/2022	1,405	0.0%	24,115	12/31/2021
2021 Q3	11/15/2021	1,448	0.0%	24,115	9/30/2021
2014 Q1	5/23/2014	5,570	0.0%	85,852	3/31/2014